Just In
- 6 hrs ago Heeramandi Screening: Alia Bhatt, Ananya Panday, Rashmika Mandanna And Others Serve Finest Ethnic Style!
- 7 hrs ago From Alia Bhatt To Kriti Sanon, Korean Beauty Products That Bollywood Divas Swear By
- 10 hrs ago Exclusive: On World Malaria Day 2024, Dr Shares Danger Signs Parents Must Watch Out For In Child With Malaria
- 10 hrs ago Exclusive: Expert Debunks 5 Common Misconceptions About Expectant Mothers That You Need To Steer Clear From
Don't Miss
- News King Charles Grants Royal Assent: UK's Rwanda Deportation Plan Now Law
- Sports T20 World Cup 2024: Toss up between Sanju Samson and KL Rahul ahead of big selection meeting
- Movies Giorgia Andriani Turns Up Heat As She Flaunts Toned Body In Black Bra, Skirt Post Gym Session- VIRAL VIDEO
- Finance IndusInd Bank Q4 Results: PAT Soars 15% To Rs 2,349 Cr, NII Climbs 15%; 165% Dividend Declared
- Automobiles Royal Enfield Unveils Revolutionary Rentals & Tours Service: Check Out All Details Here
- Technology Elon Musk’s X Is Launching a TV App Similar to YouTube for Watching Videos
- Education AICTE introduces career portal for 3 million students, offering fully-sponsored trip to Silicon Valley
- Travel Escape to Kalimpong, Gangtok, and Darjeeling with IRCTC's Tour Package; Check Itinerary
SII Gets DCGI Nod To Manufacture Drug Substance, Test It For Developing Jab Against Omicron
India's drug regulator on Friday approved Serum Institute of India's proposal to manufacture a drug substance for the new Covid vaccine against the Omicron variant of coronavirus and carry out its testing and analysis, official sources said.
The move assumes significance in view of the country reporting a rise in daily new Covid-19 cases which include the Omicron variant.
Looking to undertake vaccine research against the Omicron variant, Director, Government and Regulatory Affairs at SII, Prakash Kumar Singh, recently had submitted an application to the Drugs Controller General of India (DCGI) for grant of permission to manufacture Drug substance of SARS-CoV-2 rS Protein (Covid-l9)Recombinant Spike Nanoparticle Vaccine (Omicron Variant) for examination test and analysis.
"As you are aware, the new coronavirus variant 'Omicron' has already been reported in more than 60 countries and is spreading very fast worldwide and in our country also. Our CEO Adar C Poonawalla is very much concerned about the protection of citizens of our country and world at large against coronavirus and its new variants, and we are relentlessly working on the development of SARS-CoV-2 rS Protein (Covid-19) Recombinant Spike Nanoparticle Vaccine (Omicron Variant)," an official source quoted Singh as having said in the application.
Development of this vaccine shall be another example of vaccine production strength of India in line with the clarion call of Prime Minister Narendra Modi "Making in India for the World" and shall further keep our country's flag flying high globally, he said.
After the review of their application, DCGI has given permission to manufacture SARS-CoV-2 rS Drug Substance (Omicron Variant) for Examination, Test and Analysis (for SIIPL Hadapsar site), an official source informed.
- kidsDCGI Panel To Review On Friday SII Applications For Covovax’s Use Among Kids Aged 2-7 Yrs, 7-11 Yrs
- wellnessDCGI Approves India's First qHPV Vaccine Against Cervical Cancer
- disorders cureDRDO’s Anti-COVID Drug Named 2DG Cleared For Emergency Use In India By DCGI: All You Need To Know
- health4 Diseases You Can Take Vaccine For Even After You Turn 40: Is It Too Late to Get Hepatitis B Vaccine?
- healthNobel Prize 2023: Scientists Behind The COVID-19 mRNA Vaccines Wins
- healthCOVID-19 Vaccines and Heart Attacks: New Studies Show Different Results; What Are They?
- healthCancer, Heart Disease Vaccine To Be Ready By 2030: Know More Here
- healthXBB.1.16: Symptoms; Are Vaccines Useful? WHO Concerned Over Recent COVID Spike In India
- wellnessNational Vaccination Day: List Of Vaccines Every Adult Over 50 Should Get
- disorders cureNational Vaccination Day 2023: Diseases For Which No Vaccines Are Currently Available
- disorders cureCervical Cancer: Serum Institute Of India Launches First HPV Vaccine For Cervical Cancer
- wellnessDissolving Vaccine Tablets For Urinary Tract Infections: Important Points